Role of interferon-γ in murine cytomegalovirus infection

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 2, 1998, Pages 124-133

  Pomeroy, Claire ^a   Delong, David ^b   Clabots, Connie ^b   Riciputi, Paul ^b   Filice, Gregory A ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031871978     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90007-5     Document Type: Article

References (24)

1. Murray HW. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 1988;108:595-608.
2. Grundy JE, Trapman J, Allan JE, Shellam GR, Melief CJ. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H2-linked genes. Infect Immun 1982;37:143-50.
3. Leist TP, Eppler M, Zinkemagel RM. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J Virol 1989;63:2813-9.
4. Fennie EH, Lie YS, Low MA, Gribling P, Anderson KP. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-γ treatment. Antiviral Res 1988;10:27-39.
5. Grundy JE, Mackenzie JS, Stanley NF. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 1981;32:277-86.
6. Pomeroy C, Hilleren PJ, Jordan MC. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 1991;65:3330-4.
7. Pomeroy C, Kline S, Jordan MC, Filice GA. Reactivation of Toxoplasma gondii by cytomegalovirus in mice: antimicrobial activities of macrophages. J Infect Dis 1989;160:305-11.
8. Selgrade MK, Collier AM, Saxton L, Daniels MJ, Graham JA. Comparison of the pathogenesis of murine cytomegalovirus in lung and liver following intraperitoneal or intratracheal infection. J Gen Virol 1984;65:515-23.
9. Pomeroy C, Filice GA, Hitt JA, Jordan MC. Cytomegalovirus-induced reactivation of Toxoplasma gondii pneumonia in mice: lung lymphocyte phenotypes and suppressor function. J Infect Dis 1992;166:677-81.
10. McCabe RE, Lufi BJ, Remington JS. Effect of murine interferon-γ on murine toxoplasmosis. J Infect Dis 1984:150: 961-2.
11. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045-56.
12. Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in NK cell IFN-γ production and antiviral defense. J Immunol 1996:156:1138-42.
13. Shanley JD, Goff E, Debs RJ, Forman SJ. The role of tumor necrosis factor-α in acute murine cytomegalovirus infection in BALB/c mice. J Infect Dis 1994;169:1088-91.
14. Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 1981;126:988-94.
15. Haagmans BL, Schijns VECG, Ven der Eertwegh AJM, Classen E, Horzinck MC. Role of tumor necrosis factor during cytomegalovirus infection in immunosuppressed rats: activation of virus replication. In: Mossman T, Abbas A, editors. New advances on cytokines. New York: Raven Press, 1992;277-82.
16. Haagmans BL, van der Meide PH, Stals FS, van den Eertwegh AJ, Claassen E, Bruggeman CA, et al. Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J Virol 1994;68:2305-12.
17. Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, et al. Interferon γ induces the expression of HIV in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992;176:739-50.
18. Olsson T, Bakhiet M, Edlund C, Hojeberg B, Van der Meide PH, Kristensson K. Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth. Eur J Immunol 1991;21:2447-54.
19. Schut RL, Gekker G, Hu S, et al. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J Infect Dis 1994; 169:1092-6.
20. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 1992;66:1977-84.
21. Pavic I, Polic B, Crnkovic I, Lucin P, Jonjic S, Koszinowski UH. Participation of endogenous tumor necrosis factor α in host resistance to cytomegalovirus infection. J Gen Virol 1993;74:2215-23.
22. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH. Restoration of cytomegalovirus antigen presentation by gamma Interferon combats viral escape. J Virol 1994;68:289-97.
23. Heagy W, Groopman J, Schindler J, Finberg R. Use of interferon-gamma in patients with AIDS. Journal of Acquired Immune Deficiency Syndrome 1990;3:584-90.
24. Gallin JI. Interferon-γ in the management of infectious diseases. Ann Intern Med 1995;123:216-24.